Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377062 | 12537706 | 2 | F | 20160419 | 20160725 | 20160707 | 20160809 | EXP | JP-ASTELLAS-2016US025578 | ASTELLAS | 67.00 | YR | M | Y | 0.00000 | 20160809 | CN | GB | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377062 | 12537706 | 1 | PS | AMBISOME | AMPHOTERICIN B | 1 | Intravenous drip | 2850 | MG | 50740 | 150 | MG | INJECTION | QD | |||||
| 125377062 | 12537706 | 2 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | U | 0 | 2000 | MG | FORMULATION UNKNOWN | |||||||
| 125377062 | 12537706 | 3 | C | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | U | 0 | 500 | MG | FORMULATION UNKNOWN | |||||||
| 125377062 | 12537706 | 4 | C | MEROPENEM. | MEROPENEM | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 125377062 | 12537706 | 5 | C | Teicoplanin | TEICOPLANIN | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | INJECTION | ||||||||
| 125377062 | 12537706 | 6 | C | RED BLOOD CELLS, CONCENTRATED | HUMAN RED BLOOD CELL | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 125377062 | 12537706 | 7 | C | PLATELETS | HUMAN PLATELET, ALLOGENIC | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125377062 | 12537706 | 1 | Febrile neutropenia |
| 125377062 | 12537706 | 2 | Product used for unknown indication |
| 125377062 | 12537706 | 3 | Product used for unknown indication |
| 125377062 | 12537706 | 4 | Product used for unknown indication |
| 125377062 | 12537706 | 5 | Product used for unknown indication |
| 125377062 | 12537706 | 6 | Product used for unknown indication |
| 125377062 | 12537706 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125377062 | 12537706 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125377062 | 12537706 | Alanine aminotransferase increased | |
| 125377062 | 12537706 | Aspartate aminotransferase increased | |
| 125377062 | 12537706 | Blood bilirubin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125377062 | 12537706 | 1 | 20160401 | 20160419 | 0 | |
| 125377062 | 12537706 | 2 | 20160415 | 20160419 | 0 | |
| 125377062 | 12537706 | 3 | 20160408 | 20160504 | 0 | |
| 125377062 | 12537706 | 4 | 20160404 | 0 | ||
| 125377062 | 12537706 | 5 | 20160408 | 20160420 | 0 | |
| 125377062 | 12537706 | 6 | 20160411 | 20160411 | 0 | |
| 125377062 | 12537706 | 7 | 20160404 | 20160404 | 0 |